Literature DB >> 17084546

A magnetic resonance imaging study of prostate deformation relative to implanted gold fiducial markers.

Alan M Nichol1, Kristy K Brock, Gina A Lockwood, Douglas J Moseley, Tara Rosewall, Padraig R Warde, Charles N Catton, David A Jaffray.   

Abstract

PURPOSE: To describe prostate deformation during radiotherapy and determine the margins required to account for prostate deformation after setup to intraprostatic fiducial markers (FM). METHODS AND MATERIALS: Twenty-five patients with T1c-T2c prostate cancer had three gold FMs implanted. The patients presented with a full bladder and empty rectum for two axial magnetic resonance imaging (MRI) scans using a gradient recalled echo (GRE) sequence capable of imaging the FMs. The MRIs were done at the time of radiotherapy (RT) planning and a randomly assigned fraction. A single observer contoured the prostate surfaces. They were entered into a finite element model and aligned using the centroid of the three FMs.
RESULTS: During RT, the prostate volume decreased by 0.5%/fraction (p = 0.03) and the FMs in-migrated by 0.05 mm/fraction (p < 0.05). Prostate deformation was unrelated to differential bladder and bowel filling, but was related to a transurethral resection of the prostate (TURP) (p = 0.003). The standard deviation for systematic uncertainty of prostate surface contouring was 0.8 mm and for FM centroid localization was 0.4 mm. The standard deviation of random interfraction prostate deformation was 1.5 mm and for FM centroid variability was 1.1 mm. These uncertainties from prostate deformation can be incorporated into a margin recipe to determine the total margins required for RT.
CONCLUSIONS: During RT, the prostate exhibited: volume decrease, deformation, and in-migration of FMs. Patients with TURPs were prone to prostate deformation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17084546     DOI: 10.1016/j.ijrobp.2006.08.021

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  56 in total

1.  Motion-compensated estimation of delivered dose during external beam radiation therapy: implementation in Philips' Pinnacle(3) treatment planning system.

Authors:  Shyam Bharat; Parag Parikh; Camille Noel; Michael Meltsner; Karl Bzdusek; Michael Kaus
Journal:  Med Phys       Date:  2012-01       Impact factor: 4.071

2.  A novel technique to enable experimental validation of deformable dose accumulation.

Authors:  Carolyn J Niu; Warren D Foltz; Michael Velec; Joanne L Moseley; Adil Al-Mayah; Kristy K Brock
Journal:  Med Phys       Date:  2012-02       Impact factor: 4.071

3.  Dosimetric effect of intrafraction motion and residual setup error for hypofractionated prostate intensity-modulated radiotherapy with online cone beam computed tomography image guidance.

Authors:  Justus Adamson; Qiuwen Wu; Di Yan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-18       Impact factor: 7.038

Review 4.  MR-guided prostate interventions.

Authors:  Clare Tempany; Sarah Straus; Nobuhiko Hata; Steven Haker
Journal:  J Magn Reson Imaging       Date:  2008-02       Impact factor: 4.813

5.  Phantom measurements to quantify the accuracy of a commercially available cone-beam CT gray-value matching algorithm using multiple Fiducials.

Authors:  Frederick Marc Köhler; Judit Boda-Heggemann; Beate Küpper; Dirk Wolff; Hansjörg Wertz; Frank Lohr; Frederik Wenz
Journal:  Strahlenther Onkol       Date:  2009-02-18       Impact factor: 3.621

6.  Intrafractional motion of the prostate during hypofractionated radiotherapy.

Authors:  Yaoqin Xie; David Djajaputra; Christopher R King; Sabbir Hossain; Lijun Ma; Lei Xing
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-09-01       Impact factor: 7.038

7.  Fiducial marker for prostate radiotherapy: comparison of 0.35- and 0.5-mm-diameter computed tomography and magnetic resonance images.

Authors:  Osamu Tanaka; Hisao Komeda; Takayoshi Iida; Masayoshi Tamaki; Kensaku Seike; Daiki Kato; Shigeki Hirose; Daisuke Kawaguchi; Takamasa Yokoyama
Journal:  Radiol Med       Date:  2016-12-15       Impact factor: 3.469

8.  Is it essential to use fiducial markers during cone-beam CT-based radiotherapy for prostate cancer patients?

Authors:  Berna A Yildirim; Cem Onal; Yemliha Dolek
Journal:  Jpn J Radiol       Date:  2016-10-11       Impact factor: 2.374

9.  Comparison of dose decrement from intrafraction motion for prone and supine prostate radiotherapy.

Authors:  Jeffrey R Olsen; Parag J Parikh; Michael Watts; Camille E Noel; Kenneth W Baker; Lakshmi Santanam; Jeff M Michalski
Journal:  Radiother Oncol       Date:  2012-07-17       Impact factor: 6.280

Review 10.  Fiducial marker guided prostate radiotherapy: a review.

Authors:  Angela G M O'Neill; Suneil Jain; Alan R Hounsell; Joe M O'Sullivan
Journal:  Br J Radiol       Date:  2016-09-23       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.